CYP 517 (Uritact-EC 0.06 mg-81.6 mg-10.8 mg-36.2 mg)
Generic Name: hyoscyamine/methenamine/methylene blue/phenyl salicylate
Pill with imprint CYP 517 is Blue, Round and has been identified as Uritact-EC 0.06 mg-81.6 mg-10.8 mg-36.2 mg. It is supplied by Cypress Pharmaceutical Inc.
Uritact-EC is used in the treatment of urinary tract infection and belongs to the drug class urinary antispasmodics. Risk cannot be ruled out during pregnancy. Uritact-EC 0.06 mg-81.6 mg-10.8 mg-36.2 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for CYP 517
- Generic Name:
- hyoscyamine/methenamine/methylene blue/phenyl salicylate
- CYP 517
- 0.06 mg-81.6 mg-10.8 mg-36.2 mg
- Prescription only
- Drug Class:
- Urinary antispasmodics
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Cypress Pharmaceutical Inc
- National Drug Code (NDC):
More about Uritact-EC (hyoscyamine / methenamine / methylene blue / phenyl salicylate)
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.